InvestorsHub Logo
Followers 1
Posts 12
Boards Moderated 0
Alias Born 02/21/2014

Re: None

Tuesday, 06/30/2015 6:27:34 PM

Tuesday, June 30, 2015 6:27:34 PM

Post# of 54032
Imun therapy
today celgene paid 1 billion for 10% of juno, an r/d for cart drugs
these drugs manipulate tcells for cancer treatment
taug owns 7% of immunotherapy,Dr harnoy,who is developing similar drugs manipulating t cells to fight cancer, he is in phase 2/3 trials several years ahead of juno
do the math
celgene valued juno with no sales at 10 billion
Stella may not be as dumb as some on this board think
Taug might be a tad undervalued at .003
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.